The Scottish Medicines Consortium(SMC) conducts rapid assessments soon after their launch of the costs and benefitsof medicines such as etanercept, an anti-tumour necrosis factor drug, which hasbeen shown in clinical trials to offer a new option for people with psoriatic arthritis.NHSScotland is expected to take account of the advice from the SMC and ensure...